COVID-19 Microvascular Evaluation Trial
Condition(s):COVID-19; Coronary Microvascular DysfunctionLast Updated:February 28, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):COVID-19; Coronary Microvascular DysfunctionLast Updated:February 28, 2024Recruiting
Condition(s):Heart Failure; Microvascular Angina; Non-ischemic CardiomyopathyLast Updated:February 6, 2024Recruiting
Condition(s):Coronary Microvascular Dysfunction; Ischemic Non-Obstructive Coronary Artery DiseaseLast Updated:August 31, 2023Completed
Condition(s):Coronary Microvascular DysfunctionLast Updated:September 7, 2023Completed
Condition(s):Coronary Microvascular Dysfunction; Resistant Hypertension; Hypertensive Heart DiseaseLast Updated:October 24, 2023Not yet recruiting
Condition(s):Microvascular DysfunctionLast Updated:April 18, 2018Completed
Condition(s):Patients With INOCA(Ischemia and no Obstructive Coronary Artery Disease) Who Have Coronary Microvascular DysfunctionLast Updated:October 25, 2018Unknown status
Condition(s):Angina CCS Classe II-IV – IMR, RFR, FFR,CFRLast Updated:March 6, 2024Recruiting
Condition(s):Coronary Artery DiseaseLast Updated:January 19, 2024Recruiting
Condition(s):Myocardial Infarction; Coronary Microvascular Dysfunction; Vasospasm, CoronaryLast Updated:January 3, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.